ESM1 and renal cell carcinoma: Moreover, immunohistochemical studies have shown that elevated ESM-1 expression correlates with unfavorable prognoses in different types of cancers, including glioblastoma, colon cancer, and hepatocellular carcinoma, as well as RCC [12, 16–18].